Complement dysregulation in human tauopathies
Jacqui Nimmo(UK Dementia Research Institute), B. Paul Morgan(UK Dementia Research Institute), Louis De Muynck(UK Dementia Research Institute), Samuel Keat(UK Dementia Research Institute)
Cited by 2
Related Papers
Inflammatory biomarkers in Alzheimer's disease plasma
|Alzheimer s & Dementia|2019|207
Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis
|Journal of Clinical Investigation|2011|129
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
|Acta Neuropathologica Communications|2022|97
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
|Alzheimer s Research & Therapy|2020|48
The complement system in neurodegenerative diseases
|Clinical Science|2024|48